智通财经APP获悉，艾美疫苗(06660)涨超7%，截至发稿，涨7.09%，报5.89港元，成交额2704.58万港元。
消息面上，艾美疫苗昨日公布，mRNA带状疱疹疫苗已于近日向中国药品监督管理局药品评审中心申报临床。临床前动物试验中，第三方检测单位的检测结果显示，集团mRNA带状疱疹疫苗特异性T细胞免疫、特异性IgG抗体滴度、膜抗原萤光抗体滴度，均显著高于市售重组亚单位对照疫苗。
集团已建立完善的mRNA疫苗质量管理体系和符合GMP标准的商业化规模生产车间，该mRNA技术平台上已经过上万例mRNA疫苗产品的人体临床试验数据验证。集团已打通mRNA疫苗研发、生产等全生命周期的流程，在完成临床后可迅速实现mRNA疫苗产品的产业化和商业化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.